FCM
BHVN

Farallon Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Farallon Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,947,820
Closed -$294M – 323
2022
Q3 		$294M Hold
1,947,820
– – 1.62% 21
2022
Q2 		$284M Buy
+1,947,820
New +$284M 1.54% 24